Otello Stampacchia, Omega Funds 🇮🇹 | Competition, Boston & Pasta | E18
We’re in Boston 🇺🇸 with top VC Otello Stampacchia of Omega Funds 🙌 We talked about...
Christina Takke, V-Bio Ventures 🇧🇪 | Wonder VC Woman | E17
We’re in San Sebastián 🇪🇸 with one of the top VCs in Europe, Christina Takke from V-Bio...
Naveed Siddiqi, Novo Holdings 🇬🇧🇩🇰 | Sharp Macro View of EU Biotech | E16
We’re in San Sebastián 🇪🇸 with Naveed Siddiqi of one of Europe’s largest biotech investors, Novo...
Claudia Ulbrich, Cardior 🇩🇪 | Being the Founder of a Rare €1B Exit | E15
We’re in Hannover 🇩🇪 with the founder and CEO of Cardior, Claudia Ulbrich We talked...
Bahija Jallal, Immunocore 🇬🇧 | Commercial, Diversity, and AI | E14
We’re super privileged to chat online with Bahija Jallal, the CEO of Immunocore. Immunocore is...
Edwin Moses | How to build large biotech platforms | E13
We’re in Brussels with Edwin Moses, the former CEO of one of the most successful...
Jens Nielsen, BII | How to make translation of life science research work | E12
We’re in Copenhagen with Jens Nielsen, the CEO of BioInnovation Institute. We will talk about...
Sander van Deventer, VectorY & Forbion | Pioneering gene therapy | E11
We’re in Amsterdam with Sander van Deventer, the CEO of VectorY. We will talk about...
Thomas Clozel, Owkin | What does AI Biotech really mean | E10
In an online special, we’re interviewing Thomas Clozal, the co-founder and CEO of Owkin. We...
Marc de Garidel, Abivax | How to make two Billion-dollar exits (“smoothly”) | E09
Today, I’m in Paris to chat with Marc de Garidel, the new CEO of Abivax....
Never Miss a New Episode 💌
Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.
Watch & Subscribe
